Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UnitedHealth Cancer Care Pilot Reduced Overall Costs Despite Higher Drug Spending

This article was originally published in The Pink Sheet Daily

Executive Summary

The bundled payment pilot program resulted in a 34% decrease in overall cancer treatment costs among participating medical centers despite a 179% increase in drug spending, according to results released July 8.

You may also be interested in...



UnitedHealth Moving, Slowly, Toward More Value-Based Drug Contracts

Insurer plans to execute more value-based contracts in next two years, but they will be pilot projects layered on top of existing rebate contracts.

Aetna Cancer Pathways Program Aims For 'Value-Based' Prescribing

“For many malignancies, there is no ‘best treatment’ but there may be tremendous differences in cost,” Aetna National Medical Director, Oncology Solutions Michael Kolodziej says.

Biosimilars Add “Urgency” To Medicare Payment Reforms – MedPAC Commissioner

Developing alternatives to the ASP-based reimbursement system for Medicare Part B drugs may become increasingly important to ensure the program will benefit from lower-cost biosimilars, Georgetown’s Jack Hoadley points out.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS077535

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel